In contrast, oestrogen signalling through ERβ produces antitumorigenic cell signalling responses in a broad range of cancers including CRC by repressing ERα transcription and activating antiproliferative cell signalling pathways (Figure 3) [103]. This evidence concerns the gene ESR1 and cancer.